Cited In for PMID: 28475832

Year	Number of Results
2017	2
2018	3
2019	2
2020	5
2021	2
2022	1

1

A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.

Esposito M, Szadocka S, Degiacomi G, Orena BS, Mori G, Piano V, Boldrin F, Zemanová J, Huszár S, Barros D, Ekins S, Lelièvre J, Manganelli R, Mattevi A, Pasca MR, Riccardi G, Ballell L, Mikušová K, Chiarelli LR. Esposito M, et al. ACS Infect Dis. 2017 Jun 9;3(6):428-437. doi: 10.1021/acsinfecdis.7b00006. Epub 2017 May 11. ACS Infect Dis. 2017. PMID: 28475832

2

Repressible Promoter System to Study Essential Genes in Mycobacteria.

Boldrin F, Manganelli R. Boldrin F, et al. Methods Mol Biol. 2022;2377:317-332. doi: 10.1007/978-1-0716-1720-5_17. Methods Mol Biol. 2022. PMID: 34709624

3

Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era.

Minias A, Żukowska L, Lechowicz E, Gąsior F, Knast A, Podlewska S, Zygała D, Dziadek J. Minias A, et al. Front Microbiol. 2021 Feb 2;11:618168. doi: 10.3389/fmicb.2020.618168. eCollection 2020. Front Microbiol. 2021. PMID: 33603720 Free PMC article. Review.

4

Vitamin in the Crosshairs: Targeting Pantothenate and Coenzyme A Biosynthesis for New Antituberculosis Agents.

Butman HS, Kotzé TJ, Dowd CS, Strauss E. Butman HS, et al. Front Cell Infect Microbiol. 2020 Dec 15;10:605662. doi: 10.3389/fcimb.2020.605662. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33384970 Free PMC article. Review.

5

Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium tuberculosis.

Grover S, Engelhart CA, Pérez-Herrán E, Li W, Abrahams KA, Papavinasasundaram K, Bean JM, Sassetti CM, Mendoza-Losana A, Besra GS, Jackson M, Schnappinger D. Grover S, et al. ACS Infect Dis. 2021 Jan 8;7(1):141-152. doi: 10.1021/acsinfecdis.0c00675. Epub 2020 Dec 15. ACS Infect Dis. 2021. PMID: 33319550 Free PMC article.

6

A Small Molecule Inhibitor of CTP Synthetase Identified by Differential Activity on a Bacillus subtilis Mutant Deficient in Class A Penicillin-Binding Proteins.

Emami K, Wu LJ, Errington J. Emami K, et al. Front Microbiol. 2020 Aug 26;11:2001. doi: 10.3389/fmicb.2020.02001. eCollection 2020. Front Microbiol. 2020. PMID: 32973723 Free PMC article.

7

Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis.

Stelitano G, Sammartino JC, Chiarelli LR. Stelitano G, et al. Molecules. 2020 Mar 9;25(5):1239. doi: 10.3390/molecules25051239. Molecules. 2020. PMID: 32182964 Free PMC article. Review.

8

THP-1 and Dictyostelium Infection Models for Screening and Characterization of Anti-Mycobacterium abscessus Hit Compounds.

Richter A, Shapira T, Av-Gay Y. Richter A, et al. Antimicrob Agents Chemother. 2019 Dec 20;64(1):e01601-19. doi: 10.1128/AAC.01601-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31636068 Free PMC article.

9

Assessing the role of Rv1222 (RseA) as an anti-sigma factor of the Mycobacterium tuberculosis extracytoplasmic sigma factor SigE.

Boldrin F, Cioetto Mazzabò L, Anoosheh S, Palù G, Gaudreau L, Manganelli R, Provvedi R. Boldrin F, et al. Sci Rep. 2019 Mar 14;9(1):4513. doi: 10.1038/s41598-019-41183-4. Sci Rep. 2019. PMID: 30872756 Free PMC article.

10

Screening of the Pathogen Box reveals new starting points for anti-trypanosomal drug discovery.

Veale CGL, Hoppe HC. Veale CGL, et al. Medchemcomm. 2018 Oct 26;9(12):2037-2044. doi: 10.1039/c8md00319j. eCollection 2018 Dec 1. Medchemcomm. 2018. PMID: 30647879 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed